Akers Biosciences Receives Notice of Delinquent Form 10-Q Filing from Nasdaq
25 mai 2018 16h30 HE
|
Akers Biosciences Inc
THOROFARE, N.J., May 25, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces...